Medistim ASA (MEDI)

Currency in NOK
224.00
0.00(0.00%)
Closed·
MEDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
224.00230.00
52 wk Range
185.00292.00
Key Statistics
Prev. Close
224
Open
225
Day's Range
224-230
52 wk Range
185-292
Volume
17.7K
Average Volume (3m)
30.14K
1-Year Change
5.1643%
Book Value / Share
27.72
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
315.00
Upside
+40.63%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 22 consecutive years

Medistim ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 315.00
(+40.63% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Medistim ASA Earnings Call Summary for Q3/2025

  • Revenue up 25.7% YoY to NOK 166.8M, slightly below forecast. EBIT grew 27.1% to NOK 40.6M. Stock rose 4.76% post-earnings.
  • Imaging systems now 50% of total system sales. U.S. market supports 37% of CABG procedures, remains key growth driver.
  • Gross margin improved to 81.5%. Profit after tax up 48% YoY to NOK 34.7M. Company exploring direct sales in France and Japan.
  • CEO highlights Asia-Pacific as medium to long-term growth engine. Vascular market growth slowed to 3.7%, presenting a challenge.
  • Analysts queried market acceptance of price increases, quarterly performance variations, and potential geographic expansion plans.
Last Updated: 10/24/2025, 04:18 PM
Read Full Transcript

Earnings

Latest Release
May 07, 2026
EPS / Forecast
-- / 1.51
Revenue / Forecast
202M / 175M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
3.57%
Industry Median 3.08%
Annualized payout
8.00
Paid annually
5-Years Growth
+21.67%
Growth Streak

MEDI Income Statement

Compare MEDI to Peers and Sector

Metrics to compare
MEDI
Peers
Sector
Relationship
P/E Ratio
26.3x17.1x−0.5x
PEG Ratio
0.990.000.00
Price/Book
8.1x2.4x2.6x
Price / LTM Sales
5.7x2.5x3.1x
Upside (Analyst Target)
37.0%25.7%54.0%
Fair Value Upside
Unlock24.7%6.5%Unlock

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Employees
159
Market
Norway

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.06M38.73%1.60B
Other Institutional Investors
12.25M61.27%2.77B
Public Companies & Retail Investors
0.000.00%0.00
Total
19.31M100.00%4.36B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Intertrade Shipping AS12.61%2,300,001515,200
Danske Capital Denmark10.00%1,824,460408,679

People Also Watch

103.90
REY
+0.39%
474.30
MUVGn
-2.37%
52.91
RLI
+0.51%
470.40
PROT
+1.25%
186.20
NORBT
-1.90%

FAQ

What Is the Medistim (MEDI) Stock Price Today?

The Medistim stock price today is 224.00 NOK.

What Stock Exchange Does Medistim Trade On?

Medistim is listed and trades on the Oslo Stock Exchange.

What Is the Stock Symbol for Medistim?

The stock symbol for Medistim is "MEDI."

Does Medistim Pay Dividends? What’s The Current Dividend Yield?

The Medistim dividend yield is 3.54%.

What Is the Medistim Market Cap?

As of today, Medistim market cap is 4.10B NOK.

When Is the Next Medistim Earnings Date?

Medistim will release its next earnings report on Aug 19, 2026.

From a Technical Analysis Perspective, Is MEDI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medistim Stock Split?

Medistim has split 0 times.

How Many Employees Does Medistim Have?

Medistim has 159 employees.

What is the current trading status of Medistim (MEDI)?

As of May 21, 2026, Medistim (MEDI) is trading at a price of 224.00 NOK, with a previous close of 224.00 NOK. The stock has fluctuated within a day range of 224.00 NOK to 230.00 NOK, while its 52-week range spans from 185.00 NOK to 292.00 NOK.

What Is Medistim (MEDI) Price Target According to Analysts?

The average 12-month price target for Medistim is 315.00 NOK, with a high estimate of 320 NOK and a low estimate of 310 NOK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +40.63% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.